486 related articles for article (PubMed ID: 19292069)
21. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S
Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739
[TBL] [Abstract][Full Text] [Related]
22. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
23. [Proteinchip profiling of tumor markers in lung adenocarcinoma tissue from non-smoking oriental female patients].
Au JS; Cho CS; Yip TT; Law SC
Ai Zheng; 2008 Mar; 27(3):264-71. PubMed ID: 18334115
[TBL] [Abstract][Full Text] [Related]
24. Direct analysis of laser capture microdissected endometrial carcinoma and epithelium by matrix-assisted laser desorption/ionization mass spectrometry.
Guo J; Colgan TJ; DeSouza LV; Rodrigues MJ; Romaschin AD; Siu KW
Rapid Commun Mass Spectrom; 2005; 19(19):2762-6. PubMed ID: 16134212
[TBL] [Abstract][Full Text] [Related]
25. Biomarker discovery for ovarian cancer using SELDI-TOF-MS.
Zhang H; Kong B; Qu X; Jia L; Deng B; Yang Q
Gynecol Oncol; 2006 Jul; 102(1):61-6. PubMed ID: 16403569
[TBL] [Abstract][Full Text] [Related]
26. [Establish predictive model of colorectal cancer by using surface enhanced laser desorption/ionization-time of flight-mass spectrometry].
Lai YH; Xu JM; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):995-7. PubMed ID: 19035201
[TBL] [Abstract][Full Text] [Related]
27. Deep proteome profiling of sera from never-smoked lung cancer patients.
Au JS; Cho WC; Yip TT; Yip C; Zhu H; Leung WW; Tsui PY; Kwok DL; Kwan SS; Cheng WW; Tzang LC; Yang M; Law SC
Biomed Pharmacother; 2007 Oct; 61(9):570-7. PubMed ID: 17913442
[TBL] [Abstract][Full Text] [Related]
28. Study of distinct protein profiles for early diagnosis of NSCLC using LCM and SELDI-TOF-MS.
Yang S; Nan Y; Tian Y; Zhang W; Zhou B; Bu L; Huo S; Chen G; Yu J; Zheng S
Med Oncol; 2008; 25(4):380-6. PubMed ID: 18300004
[TBL] [Abstract][Full Text] [Related]
29. [Screening urine markers of renal cell carcinoma using SELDI-TOF-MS].
Wu DL; Wang WJ; Guan M; Jin SB; Jin CR; Zhang YF
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(13):1092-5. PubMed ID: 15312509
[TBL] [Abstract][Full Text] [Related]
30. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry serum protein profiling to identify nasopharyngeal carcinoma.
Ho DW; Yang ZF; Wong BY; Kwong DL; Sham JS; Wei WI; Yuen AP
Cancer; 2006 Jul; 107(1):99-107. PubMed ID: 16708360
[TBL] [Abstract][Full Text] [Related]
31. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
[TBL] [Abstract][Full Text] [Related]
32. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
[TBL] [Abstract][Full Text] [Related]
33. [Screening of differentially expressed proteins associated with directional highly lymphatic metastasis in ovarian carcinoma cell lines using SELDI-TOF-MS technology].
Guan X; Li DR; Wang Q; Li L; Ruan HY; Zhang W
Ai Zheng; 2008 Nov; 27(11):1155-60. PubMed ID: 19000445
[TBL] [Abstract][Full Text] [Related]
34. [Application of SELDI-TOF-MS in detection of liver metastasis from colorectal cancer].
Shi YJ; Zhao Y; Xu JM; Lai YH; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):910-3. PubMed ID: 19173991
[TBL] [Abstract][Full Text] [Related]
35. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
[TBL] [Abstract][Full Text] [Related]
36. Quantitative quality-assessment techniques to compare fractionation and depletion methods in SELDI-TOF mass spectrometry experiments.
Harezlak J; Wang M; Christiani D; Lin X
Bioinformatics; 2007 Sep; 23(18):2441-8. PubMed ID: 17626063
[TBL] [Abstract][Full Text] [Related]
37. [Proteomic analysis of prostate cancer using surface enhanced laser desorption/ionization mass spectrometry].
Pan YZ; Xiao XY; Zhao D; Zhang L; Ji GY; Li Y; He DC; Zhao XJ; Yang BX
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3172-5. PubMed ID: 16405834
[TBL] [Abstract][Full Text] [Related]
38. [Application of serum protein fingerprint model and support vector machine in diagnosis of thyroid cancer].
Wang JX; Wang L; Fan YZ; Liu QL; Zhang J; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):979-82. PubMed ID: 16759540
[TBL] [Abstract][Full Text] [Related]
39. [Identification of serum biomarkers for ovarian cancer using protein chips and time of flight mass spectrometry technology].
Wang Q; Li L; Li DR; Zhang W; Wei X; Zhang JQ; Tang Y
Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):544-8. PubMed ID: 17083841
[TBL] [Abstract][Full Text] [Related]
40. Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology.
Scarlett CJ; Smith RC; Saxby A; Nielsen A; Samra JS; Wilson SR; Baxter RC
Gastroenterology; 2006 May; 130(6):1670-8. PubMed ID: 16697731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]